Stay updated on ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial page
- Check4 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check12 days agoChange DetectedMinor UI/layout adjustments and an updated timestamp; no substantive changes to core study content such as eligibility, primary outcomes, or treatment details.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedA new Revision: v3.4.2 is now visible. The funding lapse notice and the older Revision: v3.4.1 have been removed.SummaryDifference0.5%

- Check41 days agoChange DetectedA site-wide notice about a lapse in government funding was added at the top, indicating information may not be up to date, and the page version was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check48 days agoChange DetectedThese changes are administrative UI and metadata updates (Show glossary; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0) with the removal of similar prior items (Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4); they do not modify core study content, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 on the page. This change does not affect any clinical trial details or content such as study results, eligibility criteria, or contacts. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial page.